1. Home
  2. LEGN vs PNW Comparison

LEGN vs PNW Comparison

Compare LEGN & PNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • PNW
  • Stock Information
  • Founded
  • LEGN 2014
  • PNW 1985
  • Country
  • LEGN United States
  • PNW United States
  • Employees
  • LEGN N/A
  • PNW N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • PNW Electric Utilities: Central
  • Sector
  • LEGN Health Care
  • PNW Utilities
  • Exchange
  • LEGN Nasdaq
  • PNW Nasdaq
  • Market Cap
  • LEGN 9.1B
  • PNW 10.2B
  • IPO Year
  • LEGN 2020
  • PNW N/A
  • Fundamental
  • Price
  • LEGN $38.19
  • PNW $91.51
  • Analyst Decision
  • LEGN Strong Buy
  • PNW Buy
  • Analyst Count
  • LEGN 13
  • PNW 12
  • Target Price
  • LEGN $81.46
  • PNW $80.79
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • PNW 1.6M
  • Earning Date
  • LEGN 11-12-2024
  • PNW 11-06-2024
  • Dividend Yield
  • LEGN N/A
  • PNW 3.90%
  • EPS Growth
  • LEGN N/A
  • PNW 27.39
  • EPS
  • LEGN N/A
  • PNW 5.34
  • Revenue
  • LEGN $520,183,000.00
  • PNW $5,021,081,000.00
  • Revenue This Year
  • LEGN $110.04
  • PNW $5.00
  • Revenue Next Year
  • LEGN $77.16
  • PNW $3.69
  • P/E Ratio
  • LEGN N/A
  • PNW $17.20
  • Revenue Growth
  • LEGN 122.96
  • PNW 6.52
  • 52 Week Low
  • LEGN $38.02
  • PNW $65.20
  • 52 Week High
  • LEGN $70.13
  • PNW $93.12
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.40
  • PNW 60.44
  • Support Level
  • LEGN $38.94
  • PNW $90.53
  • Resistance Level
  • LEGN $41.87
  • PNW $93.12
  • Average True Range (ATR)
  • LEGN 2.20
  • PNW 1.81
  • MACD
  • LEGN -0.30
  • PNW 0.37
  • Stochastic Oscillator
  • LEGN 1.74
  • PNW 79.20

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About PNW Pinnacle West Capital Corporation

Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility that serves 1.4 million customers across a 35,000-square-mile territory in central Arizona, including Phoenix. APS owns or leases more than 6 gigawatts of power generation capacity, including a 29% ownership stake in the largest nuclear plant in the US, Palo Verde. About half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.

Share on Social Networks: